Infection and rejection in liver transplant patients: A 10-year Swiss single-centre experience

Swiss Medical Weekly

Volumn 135, Issue 39-40, 2005, Pages 587-593

  Garbino, Jorge ^a   Romand, Jacques André ^a   Pittet, Didier ^a   Giostra, Emiliano ^a   Mentha, Gilles ^a   Suter, Peter ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Acute rejection; Bacterial; Candidaemia; Fungal infections; Infection; Liver transplantation; Viral

Indexed keywords

AZATHIOPRINE; CEFUROXIME; CYCLOSPORIN; GANCICLOVIR; METHYLPREDNISOLONE; MUROMONABUN CD3; NEOMYCIN; NYSTATIN; OKT 3; POLYMYXIN B; PREDNISONE; T LYMPHOCYTE ANTIBODY; TACROLIMUS; UNCLASSIFIED DRUG; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL INFECTION; COHORT ANALYSIS; FEMALE; GRAFT REJECTION; HUMAN; INFECTION RISK; INFECTIOUS COMPLICATION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MYCOSIS; PROTOZOAL INFECTION; RETROSPECTIVE STUDY; SWITZERLAND; VIRUS INFECTION;

EID: 28944447238     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Ascher NL, Stock PG, Bumgardner GL, Payne WD, Najarian JS. Infection and rejection of primary hepatic transplant in 93 consecutive patients treated with triple immunosuppressive therapy. Surg Gynecol Obstet 1988;167:474-84.
2. Kusne S, Dummer JS, Singh N, Iwatsuki S, Makowska L, Esquivel C, et al. Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) 1988;67:132-43.
3. Paya CV, Hermans PE, Washington JA, Smith TF, Anhalt JP, Wiesner RH, et al. Incidence, distribution, and outcome of episodes of infection in 100 orthotopic liver transplantations. Mayo Clin Proc 1989;64:555-64.
4. Colonna JO, Winston DJ, Brill JE, Goldstein LI, Hoff MP, Hiatt JR, et al. Infectious complications in liver transplantation. Arch Surg 1988;123:360-4.
5. Barkholt L, Ericzon BG, Tollemar J, Malmborg AS, Ehrnst A, Wilczek H, et al. Infections in human liver recipients: different patterns early and late after transplantation. Transpl Int 1993;6:77-84.
6. Snover DC, Sibley RK, Freese DK, Sharp HL, Bloomer JR, Najarian JS, et al. Orthotopic liver transplantation: a pathological study of 63 serial liver biopsies from 17 patients with special reference to the diagnostic features and natural history of rejection. Hepatology 1984;4:1212-22.
7. Sanchez-Turrion V, Cuervas-Mons V, Portera F, Barrios C, Garrido A, Albillos A. Prospective study of the incidence, timing, significance, risk factors, and outcome of cytomegalovirus infection in liver transplant patients with double-drug immunosuppression and no prophylactic antiviral therapy. Transplant Proc 1993;25:1786.
8. Pittet D. Nosocomial bloodstream infections. In: Wenzel RP, editor. Prevention and control of nosocomial infections. Boston: Williams and Wilkins; 1997:712-69.
9. Singh N, Gayowski T, Marino IR. Toxoplasma gondii pneumonitis in a liver transplant recipient: implications for diagnosis. Liver Transpl Surg 1996;2:299-300.
10. Singh N, Gayowski T, Wagener MM, Marino IR. Bloodstream infections in liver transplant recipients receiving tacrolimus. Clin Transplant 1997;11:275-81.
11. Singh N. Infectious diseases in the liver transplant recipient. Semin Gastrointest Dis 1998;9:136-46.
12. Kusne S, Schwartz M, Breinig MK, Dummer JS, Lee RE, Selby R, et al. Herpes simplex virus hepatitis after solid organ transplantation in adults. J Infect Dis 1991;163:1001-7.
13. Kusne S, Shapiro R. Surgical infections in immunocompromised patients - prevention and treatment. Adv Surg 1997;31:299-331.
14. Rosen HR, Martin P. Hepatitis B and C in the liver transplant recipient. Semin Liver Dis 2000;20:465-80.
15. Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998;338:1741-51.
16. Gayowski T, Marino IR, Singh N, Doyle H, Wagener M, Fung JJ, et al. Orthotopic liver transplantation in high-risk patients: risk factors associated with mortality and infectious morbidity. Transplantation 1998;65:499-504.
17. Singh N, Mieles L, Yu VL, Starzl TE. Decreased incidence of viral infections in liver transplant recipients. Possible effects of FK506? Dig Dis Sci 1994;39:15-18.
18. Alessiani M, Kusne S, Martin M, Jain A, Abu-Elmagd K, Moser J, et al. Infections in adult liver transplant patients under FK 506 immunosuppression. Transplant Proc 1991;23:1501-3.
19. Corti A, Sabbadini D, Pannacciulli E, Cristalli A, Fantini G, Mazza E, et al. Early severe infections after orthotopic liver transplantation. Transplant Proc 1991;23:1964.
20. Rossaint R, Raakow R, Lewandowski K, Slama K, Steffen R, Blumhardt G, et al. Strategy for prevention of infection after orthotopic liver transplantation. Transplant Proc 1991;23:1965-6.
21. Badger IL, Crosby HA, Kong KL, Baker JP, Hutchings P, Elliott TS, et al. Is selective decontamination of the digestive tract beneficial in liver transplant patients? Interim results of a prospective, randomized trial. Transplant Proc 1991;23:1460-1.
22. Steffen R, Reinhartz O, Blumhardt G, Bechstein WO, Raakow R, Langrehr JM, et al. Bacterial and fungal colonization and infections using oral selective bowel decontamination in orthotopic liver transplantations. Transpl Int 1994;7:101-8.
23. Bion JF, Badger I, Crosby HA, Hutchings P, Kong KL, Baker J, et al. Selective decontamination of the digestive tract reduces gram-negative pulmonary colonization but not systemic endotoxemia in patients undergoing elective liver transplantation. Crit Care Med 1994;22:40-9.
24. Pugin J, Auckenthaler R, Lew DP, Suter PM. Oropharyngeal decontamination decreases incidence of ventilator-associated pneumonia. A randomized, placebo-controlled, double-blind clinical trial. JAMA 1991;265:2704-10.
25. Paya CV Prevention of fungal and hepatitis virus infections in liver transplantation. Clin Infect Dis 2001;33(Suppl 1):S47-52.
26. Samuel D, Feray C. Recurrent hepatitis C after liver transplantation: clinical and therapeutical issues. J Viral Hepat 2000;7:87-92.
27. Read AE, Donegan E, Lake J, Ferrell L, Galbraith C, Kuramoto IK, et al. Hepatitis C in patients undergoing liver transplantation. Ann Intern Med 1991;114:282-4.
28. Mentha G, Giostra E, Perrin L, Widmann JJ, Stelling MJ, Easton J, et al. Prevention of viral recurrence following liver transplantation for post-hepatitis B and B-delta cirrhosis. Schweiz Med Wochenschr 1994;124:637-41.